About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,584 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,584 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 781-800 of 6,584 trials

CompletedSafety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell LymphomasThis study will evaluate the safety, antitumor activity and preliminary pharmacokinetics of an investigational drug product, DTRMWXHS-12, in patients with chronic lymphocytic…NCT02900716·Phoenix, Arizona and 5 others Active not recruitingCMV-MVA Triplex Vaccination of Stem Cell Donors in Preventing CMV Viremia in Participants With Allogeneic TransplantThis phase II trial studies how well multi-peptide CMV-modified vaccinia Ankara (CMV-MVA Triplex) vaccination of stem cell donors works in preventing cytomegalovirus (CMV) viremia…NCT03560752·Duarte, California TerminatedSelumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaThis phase II clinical trial is studying how well selumetinib works in treating patients with relapsed or refractory diffuse large B-cell lymphoma.NCT01278615·Chicago, Illinois and 15 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

RecruitingCD19x22 Chimeric Antigen Receptor T-cell Therapy (CAR T) in Pediatric B-ALLThis study will evaluate the safety and tolerability of administering a novel bispecific CD19/CD22-directed CAR T cell product (CD19x22) for the treatment of relapsed or…NCT06559189·Aurora, Colorado

TerminatedTreatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate MofetilRATIONALE: Giving chemotherapy and total-body irradiation before a donor umbilical cord blood transplant helps stop the growth of cancer and abnormal cells and helps stop the…NCT00608517·Nashville, Tennessee and 3 others

RecruitingPre-malignant States to Hematologic Malignancies in FirefightersThe purpose of the study is to evaluate if firefighter exposure to hazardous compounds will increase the incidence of premalignant hematological states which subsequently…NCT06870760·Charlotte, North Carolina

Active not recruitingA Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's LymphomaThis is a phase I/II, open-label, dose-escalation study designed to evaluate the safety, tolerability, and efficacy of englumafusp alfa (RO7227166) in participants with…NCT04077723·Pasadena, California and 34 others

CompletedPhase I Study of OPB-51602 in Patients With Hematologic MalignanciesTo determine the maximum tolerated dose (MTD) of OPB-51602NCT01344876·Nagoya and 1 other

CompletedBiomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell NeoplasmsRATIONALE: Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related…NCT01390597

Active not recruitingA Study of Ibrutinib With Rituximab in People With Untreated Marginal Zone LymphomaThe purpose of this study is to see if the combination of rituximab and ibrutinib can help people with marginal zone lymphoma who have not received treatment in the past.NCT04212013·Washington D.C., District of Columbia and 9 others

WithdrawnHMPL-760 Safety and Tolerability Study in Patients With Previously Treated CLL/SLL or NHLAn open label single-arm clinical trial to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of HMPL-760 in patients with previously treated CLL/SLL or NHLNCT05176691·Anaheim, California and 35 others

RecruitingAlpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant DiseasesThis study will assess the safety, efficacy, and feasibility of ⍺/β CD3+ T-cell and CD19+ B-cell depletion in allogeneic stem cell transplantation in patients with acute…NCT05800210·Gainesville, Florida

RecruitingAntigen Targeted T Cell Therapy for Relapsed/Refractory B Cell LymphomasThis is a single center, open label, phase 1 lead in to determine Recommended Phase 2 Dose (RP2D), followed by a phase 2 trial to evaluate the safety and efficacy of Epo-R-CD19…NCT07319676·Singapore, Singapore

WithdrawnStudy of Efficacy and Safety of CTL019 in Adult ALL PatientsThis is a single arm, open-label, multi-center, phase II study to determine the efficacy and safety of CTL019 in adult patients with r/r B-cell ALL.NCT02167360

Active not recruitingClinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic CancerBackground: * Individuals may be prone to develop blood or lymph node cancers (leukemia or lymphoma) for a variety of reasons, including genetic predisposition to these cancers…NCT00039676·Bethesda, Maryland and 1 other

UnknownStudy of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular LymphomaThe primary objective of this Phase 3 study is to definitively confirm the safety and efficacy of BiovaxId, an autologous tumor derived immunoglobulin idiotype vaccine, as…NCT00091676

CompletedStudy of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)This is an open-label, multicenter study to characterize the safety and efficacy of the human anti-CD19 antibody MOR00208 in adult patients with relapsed/refractory non-Hodgkin's…NCT01685008·Norwalk, Connecticut and 21 others

TerminatedA Study of the Effects of AB-205 in Patients With Lymphoma Undergoing Autologous Hematopoietic Cell TransplantationHigh-dose chemotherapy followed by blood stem cell transplantation is administered to lymphoma patients with an intention to cure.NCT05181540·Gilbert, Arizona and 27 others

CompletedRituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell LymphomaRATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00101010·Fort Smith, Arkansas and 6 others

UnknownAlemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies, such as alemtuzumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread.NCT00363090·Vancouver, British Columbia and 4 others

PreviousPage 40 of 330Next